Chuanke Ning Pian (喘咳宁片)喘咳宁片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

麻黄碱是一种在国家药监局注册认定的药品。该药品含有麻黄碱-c68c215f等成分。

该药品关联的活性成分包括:麻黄碱Mahuang Jian。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:吉林省红石药业有限公司Chinese legal name: 吉林省红石药业有限公司。

您可以探索含有相同成分的其他药品:麻黄碱-c68c215f成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 喘咳宁片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 麻黄碱Mahuang Jian.

Manufacturers recorded for this product: 吉林省红石药业有限公司Chinese legal name: 吉林省红石药业有限公司.

Explore other medicines containing the same ingredient: 麻黄碱 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 喘咳宁片Recorded Chinese name: 喘咳宁片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 每片0.3gRecorded Chinese specification

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 吉林省红石药业有限公司Chinese legal name: 吉林省红石药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z22023875

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z22023875

Manufacturer

Chinese legal name: 吉林省红石药业有限公司

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字Z22023875

生产企业

吉林省红石药业有限公司

功能主治

本品止咳平喘,用于内素有里热,外又感受风寒所致的咳喘病。

用法用量

口服,一次3~4片,一日3次。

不良反应

尚不明确。

禁忌

高血压及冠状动脉病患者忌服。

注意事项

1.服药期间忌食辛辣、油腻食物。|2.本品适用于内热外寒所致的咳喘,其表现为咳呛阵作,咳痰色黄或白,粘浊稠厚,咯吐不利,汗出,面赤,口渴喜饮,不恶寒|3.咳喘急性发作,伴呼吸困难、心悸、紫绀者,或是喘息加重,表现为端坐呼吸者,或是哮病持续状态等均应去医院诊治。|4.服用三天病证无改善,应停止服用,去医院就诊。|5.服药期间,若患者出现高热,体温超过38℃,或是喘促气急加重,痰量明显增多者应到医院就诊。|6.高血压、心脏病患者慎用,本品不宜长期服用。|7.儿童、孕妇、体质虚弱者及脾胃虚寒者慎用。|8.对本品过敏者禁用,过敏体质者慎用。|9.本品性状发生改变时禁止使用。|10.儿童必须在成人监护下使用。|11.请将本品放在儿童不能接触的地方。|12.如正在使用其他药品,使用本品前请咨询医师或药师。

贮藏

密封,置阴凉处。

规格

每片0.3g

证据Evidence

  • 批准文号: 国药准字Z22023875
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.